fbpx
Tuesday, October 26, 2021
Following expert advice, FDA authorizes boosters for people 65+, high risk

Following expert advice, FDA authorizes boosters for people 65+, high risk

0
Enlarge / The Food and Drug Administration headquarters in White Oak, Maryland. Covid-19 Coverage View more stories The US Food and Drug Administration late Wednesday authorized booster doses of the Pfizer/BioNTech COVID-19 vaccine for people ages 65 and up. Also eligible for boosters will be those ages 18 to 64 who are at high risk…
How Vaccine Side Effects Compare to COVID Symptoms

How Vaccine Side Effects Compare to COVID Symptoms

0
Photo: Thaiview (Shutterstock)The COVID-19 vaccines have become somewhat notorious for their side effects: fatigue, sore arm, maybe a fever. In a few rare cases, there are more serious complications, like inflammation of the heart. So is it riskier to get a vaccine or to take your chances with COVID itself? A new study in the…
COVID boosters reportedly may start in Sept. Here’s the latest data [Updated]

COVID boosters reportedly may start in Sept. Here’s the latest data...

0
Enlarge / COVID-19 vaccine at a vaccination center in Madrid on Feb. 26, 2021. Update 8/16/2021 11 pm ET: The Biden administration has decided to recommend that most Americans get a COVID-19 vaccine booster shot eight months after their initial two-dose regimen, according to a report by the New York Times. The administration could announce…
Should Vaccinated People Mask Up Against the Delta Variant?

Should Vaccinated People Mask Up Against the Delta Variant?

Photo: Mladen Mitrinovic (Shutterstock)Los Angeles County recently asked residents to start wearing masks in public again, due to the increased risk posed by the Delta variant of the virus that causes COVID-19. Days later, the CDC director said that vaccinated people are still “safe” and still don’t need to mask up in most public settings.…
After ruining 75M J&J doses, Emergent gets FDA clearance for 25M doses

After ruining 75M J&J doses, Emergent gets FDA clearance for 25M...

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Covid-19 Coverage View more stories The US Food and Drug Administration is making progress in its efforts to sort out the fiasco at Emergent BioSolutions’ Baltimore facility, which, at this point, has ruined…
How to Time Your Kid’s COVID-19 Vaccine

How to Time Your Kid’s COVID-19 Vaccine

Photo: Pixel-Shot (Shutterstock)As the Food and Drug Administration prepares to authorize the use of Pfizer’s COVID-19 vaccine in kids ages 12-15 as soon as next week, parents should start thinking about when it makes the most sense for their child to undergo the two-dose vaccination process. Particularly if they need other vaccines for summer camps…
CDC, FDA lift pause of J&J vaccine after advisers vote in support of use [Updated]

CDC, FDA lift pause of J&J vaccine after advisers vote in...

0
Enlarge / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. Update 7:00 pm EDT: The Centers for Disease Control and Prevention and the Food and Drug Administration announced late Friday that the pause on the use of Johnson & Johnson's one-shot COVID-19 vaccine is now lifted. The announcement comes just…
CDC, FDA lift pause of J&J vaccine after advisors vote in support of use [Updated]

CDC, FDA lift pause of J&J vaccine after advisors vote in...

0
Enlarge / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. Update 4/23/2021 7:00pm ET: The Centers for Disease Control and Prevention and the Food and Drug Administration announced late Friday that the pause on the use of Johnson & Johnson's one-shot COVID-19 vaccine is now lifted. The announcement comes just…
Pause of J&J vaccine was the right call, say 88% of polled Americans

Pause of J&J vaccine was the right call, say 88% of...

0
Enlarge / General exterior view of the head office of Janssen pharmaceutical company on April 15, 2021 in Leiden, Netherlands. Covid-19 Coverage View more stories About 88 percent of Americans support the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not increase vaccine hesitancy, according to fresh data from the Axios-Ipsos Coronavirus…
More J&J troubles: Vaccine manufacturing halted and more possible clot cases

More J&J troubles: Vaccine manufacturing halted and more possible clot cases

0
Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Covid-19 Coverage View more stories The US Food and Drug Administration last week asked Emergent BioSolutions to stop making Johnson & Johnson’s COVID-19 vaccine at its troubled facility in Baltimore, according to a…

Recent Posts